← Back to Search

Platelet-Rich Plasma

Discogenic Low Back Pain for Lower Back Pain

Phase 4
Waitlist Available
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month, 2 months, 3 months, 6 months, 9 months, 12 months, 24 months, 36 months
Awards & highlights

Study Summary

This trial looks at whether a specific kind of injection can help reduce pain and improve function in people with a certain type of back pain.

Eligible Conditions
  • Lower Back Pain
  • Chronic Pain
  • Discogenic Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month, 2 months, 3 months, 6 months, 9 months, 12 months, 24 months, 36 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month, 2 months, 3 months, 6 months, 9 months, 12 months, 24 months, 36 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Numeric Rating Scale for Low Back Pain at 2-Month Follow-up
Secondary outcome measures
Median Change in Low Back Pain Numeric Rating Scale (NRS) Score
Opioid Consumption in Daily Morphine Equivalents
Oswestry Disability Index (ODI) Change Scores
+8 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Discogenic Low Back PainExperimental Treatment1 Intervention
Patient with Refractory Discogenic Low back pain who will be scheduled for platelet rich plasma injection as standard of care.

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor
1,099 Previous Clinical Trials
1,778,686 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~0 spots leftby Apr 2025